Related Experiment Video
Updated: Oct 1, 2025
09:41
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
Published on: July 19, 2019
11.6K
Pathways to cures for multiple sclerosis: A research roadmap.
Bruce F Bebo1, Mark Allegretta1, Douglas Landsman1
1National Multiple Sclerosis Society 733 3rd Ave New York, NY 10017 USA.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|March 3, 2022
Summary
A new roadmap outlines three pathways to cure Multiple Sclerosis (MS): stopping disease progression, restoring function, and preventing MS. This research plan aims to accelerate scientific breakthroughs for a cure.
Area of Science:
- Neuroimmunology
- Regenerative Medicine
- Preventive Neurology
Background:
- Multiple Sclerosis (MS) affects nearly 3 million globally, with significant research progress but no cure.
- The National MS Society is dedicated to finding cures for MS.
Purpose of the Study:
- To present the Pathways to Cures Research Roadmap, detailing knowledge gaps, milestones, and priorities.
- To recommend strategies for accelerating the development of Multiple Sclerosis cures.
Main Methods:
- Developed through engagement with scientific leaders and individuals affected by MS.
- Incorporated perspectives from over 300 people living with MS.
- Endorsed by leading Multiple Sclerosis organizations.
Main Results:
- The Roadmap identifies three interconnected pathways to cure MS: halting disease activity, restoring neurological function, and preventing new cases.
- Recommendations include better global resource alignment on high-priority research.
Conclusions:
- The developed Roadmap aims to foster collaboration and resource alignment for accelerated scientific breakthroughs.
- This initiative seeks to expedite the achievement of cures for Multiple Sclerosis.
Related Concept Videos
01:29Microorganisms in Medicine and Therapeutics
441
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
441
01:21EPS and iPS Cells in Disease Research
2.9K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.9K
01:21Satellite Stem Cells and Muscular Dystrophy
2.1K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.1K
01:22iPS Cell Differentiation
2.8K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.8K
01:22Alzheimer's Disease: Treatment
278
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
278
01:23Cystic Fibrosis: Pathogenesis
384
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
384